ATARA BIOTHERAPEUTICS INC's ticker is ATRA and the CUSIP is 046513107. A total of 117 filers reported holding ATARA BIOTHERAPEUTICS INC in Q2 2023. The put-call ratio across all filers is 0.02 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $52,491 | +8.4% | 35,467 | +18.0% | 0.00% | – |
Q2 2023 | $48,408 | -37.6% | 30,067 | +12.4% | 0.00% | – |
Q1 2023 | $77,567 | +0.8% | 26,747 | +14.0% | 0.00% | – |
Q4 2022 | $76,988 | -0.0% | 23,472 | +15.1% | 0.00% | – |
Q3 2022 | $77,000 | -37.9% | 20,396 | +27.3% | 0.00% | – |
Q2 2022 | $124,000 | -22.5% | 16,023 | +57.9% | 0.00% | – |
Q4 2021 | $160,000 | -45.6% | 10,146 | -38.3% | 0.00% | – |
Q3 2021 | $294,000 | -1.0% | 16,452 | -13.9% | 0.00% | – |
Q2 2021 | $297,000 | -33.0% | 19,119 | -38.1% | 0.00% | – |
Q1 2021 | $443,000 | -26.5% | 30,877 | +0.5% | 0.00% | – |
Q4 2020 | $603,000 | +321.7% | 30,723 | +178.9% | 0.00% | – |
Q3 2020 | $143,000 | -14.9% | 11,014 | -4.7% | 0.00% | – |
Q2 2020 | $168,000 | -66.5% | 11,560 | -8.1% | 0.00% | – |
Q1 2019 | $501,000 | +121.7% | 12,585 | +93.4% | 0.00% | – |
Q4 2018 | $226,000 | -60.4% | 6,507 | -52.8% | 0.00% | -100.0% |
Q3 2018 | $570,000 | +31.6% | 13,777 | +17.1% | 0.00% | – |
Q2 2018 | $433,000 | +102.3% | 11,765 | +114.2% | 0.00% | – |
Q1 2018 | $214,000 | – | 5,492 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Antipodean Advisors LLC | 1,000,000 | $3,280,000 | 10.95% |
M28 Capital Management LP | 439,300 | $1,440,904 | 1.37% |
Redmile Group, LLC | 6,242,756 | $20,476,240 | 0.84% |
MAVERICK CAPITAL LTD | 6,291,013 | $20,634,523 | 0.49% |
Baupost Group | 8,123,616 | $26,645 | 0.44% |
JOSH ARNOLD INVESTMENT CONSULTANT, LLC | 52,000 | $171 | 0.25% |
WASATCH ADVISORS LP | 8,391,014 | $27,522,525 | 0.18% |
PACIFIC HEIGHTS ASSET MANAGEMENT LLC | 525,000 | $1,722,000 | 0.17% |
STALEY CAPITAL ADVISERS INC | 450,000 | $1,476 | 0.09% |
Virtus ETF Advisers LLC | 36,100 | $118,408 | 0.06% |